non-Hodgkin lymphoma – Discover Pharma

Welcome to Discover Pharma! Today is : October 16, 2026

non-Hodgkin lymphoma

Advanced Therapies,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas
Enterome data link CD8 T-cell expansion to progression-free survival in lymphoma
Enterome Phase 1/2 data show EO2463-induced CD8 T-cell expansion was [...]

July 22, 2026
Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas
Heidelberg Pharma advances dual ATAC pipeline, secures $20M payment and eyes 2027 funding runway
Lead multiple myeloma candidate enters Cohort 8; second asset dosed [...]

May 5, 2026
Advanced Therapies,Drug Discovery & Development,Manufacturing & Supply Chain,Therapeutic Areas
Galapagos taps CELLforCURE by SEQENS to manufacture CAR-T therapy in France
CELLforCURE by SEQENS has partnered with Galapagos to manufacture GLPG5101, [...]

May 5, 2026
Clinical & Regulatory
Heidelberg Pharma advances lead candidates and extends cash runway
May 5, 2026

main menu

recent posts

get connected

This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.

OK